Vimarsana
Biggest News Aggregation in the World

Stanley Appel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stanley Appel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stanley Appel Today - Breaking & Trending Today

New study: Promising breakthrough in slowing the progression of ALS - Vimarsana News

New study: Promising breakthrough in slowing the progression of ALS

Data demonstrates halting of disease progression in patients with ALS at 24 weeks.

Coya Therapeutics Announces the Completion of a Controlled Phase 2 Study of Low Dose Interleukin-2 (LD IL-2) in Patients with Alzheimer's Disease - Vimarsana News

Coya Therapeutics Announces the Completion of a Controlled Phase 2 Study of Low Dose Interleukin-2 (LD IL-2) in Patients with Alzheimer's Disease

This investigator-initiated, double-blind, placebo-controlled study evaluates the safety and tolerability, biological activity, and preliminary efficacy of LD IL-2 in 38 patients with...

TOTP: 1976 - BBC Four HD - Vimarsana News

TOTP: 1976 - BBC Four HD

06/05/1976 (Season 1976): With Abba, Cliff Richard, Robin Sarstedt and Ruby Flipper. TOTP: 1976 airs on BBC Four HD at 8:30 PM, Friday 3 May. With Abba, Cliff Richard, Robin Sarstedt and Ruby Flipper

Coya Therapeutics Presents Updated ALS Biomarker Data at the 2nd Annual Johnson Center Symposium - Vimarsana News

Coya Therapeutics Presents Updated ALS Biomarker Data at the 2nd Annual Johnson Center Symposium

Serum 4-Hydroxynonenal levels are significantly increased in ALS patients- the higher the 4-HNE level, the faster the progression and shorter the survival; Serum 4-HNE levels are increased in...

Coya Therapeutics Presents ALS Biomarker Data at Society of Neuroimmune Pharmacology Conference - Vimarsana News

Coya Therapeutics Presents ALS Biomarker Data at Society of Neuroimmune Pharmacology Conference

4-Hydroxynonenal levels strongly correlate with rate of Amyotrophic Lateral Sclerosis disease progression and survival of patients from onset and diagnosis to death 4-HNE levels may serve as a...